Filing Flows › Regeneron Pharmaceuticals (REGN) › Net product sales revenue
Regeneron Pharmaceuticals (REGN) Net product sales revenue by quarter
Regeneron Pharmaceuticals' Net product sales revenue was $1.8B in Q3 2026 (third quarter 2026), +10% from Q2 2026. Over the last 7 quarters it ranged from $1.4B (Q1 2025) to $1.8B (Q3 2026).
| Quarter | Net product sales revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.8B | +10% | +14% |
| Q2 2026 | $1.6B | +7% | +0.7% |
| Q1 2026 | $1.5B | -8% | +8% |
| Q4 2025 | $1.7B | +5% | — |
| Q3 2025 | $1.6B | -3% | — |
| Q2 2025 | $1.6B | +15% | — |
| Q1 2025 | $1.4B | — | — |
Q3 2026 at a glance
Regeneron Pharmaceuticals, Q3 2026: revenue $5.1B (+36% year over year), operating margin 40.0%, net earnings $1.9B, operating cash flow $1.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is Regeneron Pharmaceuticals' Net product sales revenue?
Regeneron Pharmaceuticals' Net product sales revenue was $1.8B in Q3 2026 (third quarter 2026), +10% from Q2 2026.
How has Regeneron Pharmaceuticals' Net product sales revenue changed?
Over the last 7 quarters it ranged from $1.4B (Q1 2025) to $1.8B (Q3 2026).
Q3 2026 results → · How Regeneron Pharmaceuticals makes money →